Physician profile
Steven Beldner
NPI 1740396019
$2,605.44
in general payments reported to CMS, 2019-2025
13 companies · $543 in 2025
The $543 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2021: $117 · 2022: $722 · 2023: $306 · 2024: $623 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,472.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $645.19 | 2019-2025 | Acumed, Acumed, Innate Implant |
| Polynovo North America LLC | $277.99 | 2024-2025 | Novosorb Btm |
| Biopro, INC. | $263.18 | 2025 | Mod Thumb |
| Stryker Corporation | $246.36 | 2022-2024 | Variax |
| Abbott Laboratories | $165.67 | 2022 | |
| Axogen | $163.04 | 2025 | |
| Djo, LLC | $146.32 | 2023 | Cmf |
| Medartis INC. | $142.60 | 2023 | Aptus |
| Integra Lifesciences Corporation | $142.36 | 2022 | |
| Globus Medical, INC. | $139.98 | 2022 | |
| Endo USA, INC. | $139.34 | 2024-2025 | Xiaflex |
| Smith+Nephew, INC. | $116.61 | 2021 | |
| Skeletal Dynamics INC | $16.80 | 2023 | Ijs, Geminus, Implate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Beldner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.